SG11201701502VA - A process for the production of adenovirus - Google Patents

A process for the production of adenovirus

Info

Publication number
SG11201701502VA
SG11201701502VA SG11201701502VA SG11201701502VA SG11201701502VA SG 11201701502V A SG11201701502V A SG 11201701502VA SG 11201701502V A SG11201701502V A SG 11201701502VA SG 11201701502V A SG11201701502V A SG 11201701502VA SG 11201701502V A SG11201701502V A SG 11201701502VA
Authority
SG
Singapore
Prior art keywords
adenovirus
production
Prior art date
Application number
SG11201701502VA
Other languages
English (en)
Inventor
Brian Robert Champion
Jeetendra Bhatia
Ashvin Patel
Original Assignee
Psioxus Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201415154A external-priority patent/GB201415154D0/en
Priority claimed from GB201415581A external-priority patent/GB201415581D0/en
Application filed by Psioxus Therapeutics Ltd filed Critical Psioxus Therapeutics Ltd
Publication of SG11201701502VA publication Critical patent/SG11201701502VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201701502VA 2014-08-27 2015-08-27 A process for the production of adenovirus SG11201701502VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201415154A GB201415154D0 (en) 2014-08-27 2014-08-27 A process for the production of adenovirus
GB201415581A GB201415581D0 (en) 2014-09-03 2014-09-03 A Process
PCT/EP2015/069706 WO2016030489A2 (fr) 2014-08-27 2015-08-27 Procédé de production d'adénovirus

Publications (1)

Publication Number Publication Date
SG11201701502VA true SG11201701502VA (en) 2017-03-30

Family

ID=54062727

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201701502VA SG11201701502VA (en) 2014-08-27 2015-08-27 A process for the production of adenovirus

Country Status (6)

Country Link
US (1) US20170313990A1 (fr)
EP (1) EP3186366A2 (fr)
JP (1) JP2017529070A (fr)
KR (1) KR20170044194A (fr)
SG (1) SG11201701502VA (fr)
WO (1) WO2016030489A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3007711B1 (fr) 2013-06-14 2020-10-21 Psioxus Therapeutics Limited Posologie et formulations pour adénovirus de type b
AU2014338864C1 (en) 2013-10-25 2020-07-16 Akamis Bio Limited Oncolytic adenoviruses armed with heterologous genes
BR112018012180A2 (pt) 2015-12-17 2018-12-04 Psioxus Therapeutics Ltd vírus de codificação de um anticorpo ou fragmento de complexo anti-tcr
US11542332B2 (en) 2016-03-26 2023-01-03 Bioatla, Inc. Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof
MY197324A (en) * 2016-08-29 2023-06-13 Akamis Bio Ltd Adenovirus armed with bispecific t cell activator
GB201713765D0 (en) 2017-08-28 2017-10-11 Psioxus Therapeutics Ltd Modified adenovirus
EP3630143B1 (fr) * 2017-06-01 2023-06-07 Akamis Bio Limited Virus oncolytique et procédé
GB201801614D0 (en) 2018-01-31 2018-03-14 Psioxus Therapeutics Ltd Formulation
EP4259172A1 (fr) * 2020-12-10 2023-10-18 AstraZeneca UK Limited Procédés de fabrication d'adénovirus
WO2022170219A1 (fr) 2021-02-05 2022-08-11 Iovance Biotherapeutics, Inc. Traitement adjuvant du cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127692A0 (en) * 1996-07-01 1999-10-28 Rhone Poulenc Rorer Sa Method for producing recombinant adenovirus
GB9915413D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Propagation method
ATE491799T1 (de) * 2004-05-26 2011-01-15 Bayer Schering Pharma Ag Chimäre adenoviren zur verwendung in der krebsbehandlung
EP2094284A2 (fr) 2006-12-22 2009-09-02 Bayer Schering Pharma AG Génération d'adénovirus à activité oncolytique et utilisations de ceux-ci
CN102575233B (zh) 2009-10-15 2014-07-16 克鲁塞尔荷兰公司 从高细胞密度培养物纯化腺病毒的方法
CA2902650A1 (fr) * 2013-02-28 2014-09-04 Psioxus Therapeutics Limited Methode de production d'adenovirus
AU2014338864C1 (en) 2013-10-25 2020-07-16 Akamis Bio Limited Oncolytic adenoviruses armed with heterologous genes

Also Published As

Publication number Publication date
EP3186366A2 (fr) 2017-07-05
JP2017529070A (ja) 2017-10-05
US20170313990A1 (en) 2017-11-02
WO2016030489A2 (fr) 2016-03-03
WO2016030489A3 (fr) 2016-04-21
KR20170044194A (ko) 2017-04-24

Similar Documents

Publication Publication Date Title
HRP20201847T1 (hr) Postupak za pripremu spoja diariltiohidantoina
PL3201253T3 (pl) Sposób wytwarzania poliestrów
SG11201701502VA (en) A process for the production of adenovirus
ZA201701011B (en) Steel-strip production apparatus
PL3129335T3 (pl) Proces wytwarzania płytek
PL3129356T3 (pl) Sposób wytwarzania enzalutamidu
GB2522421B (en) LNG production process
PL3160985T3 (pl) Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylo-l-fenyloalaninoamidu
GB201506074D0 (en) Object production
GB201413778D0 (en) Methanol production process
SG11201704523WA (en) A process for the manufacture of idalopirdine
GB201415579D0 (en) A process
PL3182981T3 (pl) Sposób wytwarzania izomaltooligosacharydów
GB2532451B (en) Object production
GB201419454D0 (en) New process
IL252471A0 (en) A process for the production of idalopyridine
GB201406364D0 (en) Lactate production process
GB201415154D0 (en) A process for the production of adenovirus
GB201418664D0 (en) Methods for the production of 2-D materials
GB201407184D0 (en) Object production
GB201407180D0 (en) Object production
GB201415581D0 (en) A Process
AU2014900341A0 (en) Production process